Word: sandoz
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...maker of prescription pharmaceuticals and one of the most profitable companies on earth. But lulled by the success of Valium, whose U.S. patent expired four years ago, the company failed to keep pace in the '80s with such aggressive rivals as U.S.-based Merck and Swiss neighbors Sandoz and Ciba-Geigy. Symbolic of Hoffmann-La Roche's backward ways was the firm's thinly held stock, the most expensive traded anywhere. In the past year the price of a single share of Hoffmann-La Roche climbed to more than...
Even though HDL's relationship to coronary heart disease was first noted in 1951, many people are still not being advised by their doctors to raise their good-cholesterol levels. The reason, says Dr. Robert Levy, president of New Jersey's Sandoz Research Institute, is that there is no absolute proof that raising HDL alone can lower a person's risk of heart disease. No convincing body of evidence from animal studies has yet demonstrated the value of raising HDL, and no clinical trial to date has specifically targeted humans with low HDL. "Much the same question existed...
...four months, Oprah Winfrey's faithful viewers watched as she shed some 70 lbs. as easily as a butterfly casts off its chrysalis. Her secret? Last week the talk-show empress revealed it was Optifast, a liquid-diet program from Minneapolis-based Sandoz Nutrition. In the hours after Winfrey's program, Sandoz fielded more than 200,000 phone inquiries about its crash-diet regimen...
...month Sandoz program, offered through 460 U.S. hospitals, is designed for patients who are at least 30%, or 50 lbs., over their ideal weight. Typical cost of the six-month program...
Enter cyclosporine. Discovered in 1970 by a scientist at Sandoz, a Swiss pharmaceutical company, the drug was nearly abandoned as worthless. Unexpectedly, however, researchers found that it was a highly selective suppressor of helper T cells. By preventing the activation of the T cells, the drug interferes with the body's instinct to attack a transplanted organ. Yet unlike other suppressants, it does not affect other parts of the immune system. Cyclosporine is thus able to dampen the rejection reaction while leaving a large part of the body's infection-fighting defenses intact...